Abstract:
A two-chamber type combined container-syringe includes an outer tube (10) formed in a tubular shape having a uniform inner diameter about an axis (O) thereof throughout the axis direction and provided with a bypass groove (11a) concaved from an inner circumferential surface in a portion in the axis direction, wherein the inner diameter of the outer tube (10) is 6.0 mm or more and 10.0 mm or less, the plurality of bypass grooves are formed in the circumferential direction of the axis at intervals, a cross-sectional area of the bypass groove perpendicular to the axis is 0.13% or more and 0.24% or less of an inner circumferential cross-sectional area of the outer tube perpendicular to the axis, and a depth of the bypass groove concaved from the inner circumferential surface is 2.7% or more and 3.8% or less of the inner diameter of the outer tube. As a result, solution can smoothly flow through the bypass groove, and an amount of solution remaining in the bypass groove can be reduced.
Abstract:
A cartridge set including: a plurality of cartridges; a plurality of holders, each of which has an upper end externally fitted to the outer peripheral surface of each of the cartridges, and has a lower end face whose outer diameter is greater than the outer diameter of the outer peripheral surface of the cartridge; a supporting plate that has a plurality of through-holes, each of which has an inner diameter greater than the outer diameter of the outer peripheral surface of the cartridge and has each of the plurality of cartridges inserted therethrough; a storage box that stores the supporting plate therein; and a lid member that blocks an upper end opening of the storage box.
Abstract:
A manufacturing method of two-chamber type combined container-syringe including: a vacuum plugging process (S2) of eliminating air bubbles from the dissolving solution of the dissolving solution-filled cartridge and sealing the dissolving solution with a middle stopper after the dissolving solution filling process (S1); a vacuum plugging process (S2) has a first cooling processing (S21) of cooling the inside of a vacuum plugging equipment in which a dissolving solution-filled cartridge is disposed to a cooling temperature that does not freeze the dissolving solution, a first decompression processing (S23) of decreasing a pressure inside the vacuum plugging equipment while the vacuum plugging equipment maintains the cooling temperature after the first cooling processing (S21), and a middle stopper pushing processing (S24) of pushing the middle stopper downward and bringing the middle stopper into contact with the dissolving solution after the first decompression processing (S23). The dissolving solution can be easily filled in a bubble-free state in the two-chamber type combined container-syringe.
Abstract:
A two-chamber type combined container-syringe includes an outer tube (10) formed in a tubular shape having a uniform inner diameter about an axis (O) thereof throughout the axis direction and provided with a bypass groove (11a) concaved from an inner circumferential surface in a portion in the axis direction, wherein the inner diameter of the outer tube (10) is 6.0 mm or more and 10.0 mm or less, the plurality of bypass grooves are formed in the circumferential direction of the axis at intervals, a cross-sectional area of the bypass groove perpendicular to the axis is 0.13% or more and 0.24% or less of an inner circumferential cross-sectional area of the outer tube perpendicular to the axis, and a depth of the bypass groove concaved from the inner circumferential surface is 2.7% or more and 3.8% or less of the inner diameter of the outer tube. As a result, solution can smoothly flow through the bypass groove, and an amount of solution remaining in the bypass groove can be reduced.
Abstract:
A device for accommodating a freeze-dried pharmaceutical product (S) for reconstitution, comprising: a vessel (1) having at its opening end (3) an opening edge (4) and an adjoining longitudinal portion (5) with an evenly formed inner cross section, a front plunger (2) to be positioned inside the vessel (1) at the longitudinal portion (5), wherein the front plunger (2) is configured to be positioned inside the vessel (1) in a sealing state, in which the front plunger (2) is fully inserted in the vessel (1), or in an exchange state, in which the front plunger (2) is inserted partly in the vessel (1) and partly protrudes over the opening edge (4) of the vessel (1), and wherein the front plunger (2) comprises sealing means that are configured to seal the inside of the vessel (1) against the outside when the front plunger (2) is positioned in the sealing state, and one or more communicating grooves (2i) that are configured to place the inside and outside of the vessel (1) in communication with each other when the front plunger (2) is positioned in the exchange state, is characterized in that the sealing means are dimensioned and/or structured in such a way that the front plunger (2), when an underpressure of predefined strength is applied to the outer environment of the vessel (1), is caused to move inside the vessel (1) toward its opening end (3). Furthermore, a method of manufacturing a sealed vessel (1) accommodating a freeze-dried pharmaceutical product (S) is disclosed.